Patent

India’s Biosimilar Pathway Gets an Update in the Draft 2025 Guidelines

IntroductionIndia’s regulatory landscape for biologic and biosimilar medicines continues to evolve.In response to scientific advances and accumulated regulatory experience, the CentralDrugs Standard Control Organization (CDSCO) and the Department of Biotechnology(DBT) have jointly released the Draft Guidelines on Similar Biologics – RegulatoryRequirements for Marketing Authorization in India, 2025. These proposed guidelinesrevise the earlier 2016 version, building […]
Read more

A Power of Attorney Dispute that Went Too Far

In a significant judgment dated April 22, 2025, the Calcutta High Court (Original Side, Intellectual Property Rights Division) allowed Huawei Technologies Co. Ltd. v. Controller General of Patents, Designs, and Trademarks [1]1, emphatically setting aside a 40-page rejection order passed by the Controller of Patents. The Court held that the application had been rejected not […]
Read more

Trade Secret Protection in India: A Comprehensive Overview

Introduction Trade secrets are crucial to modern business strategy, particularly in sectors driven by innovation, technology, or unique practices. Unlike patents, which require formal registration and public disclosure, trade secrets are protected through confidentiality and non-disclosure agreements (NDAs). In India, the growing importance of trade secret protection is driven by intensifying local and global competition. […]
Read more

Delhi High Court Reins in Patent Claim Amendments: AbbVie’s Attempt to Convert Method Claims Rejected

Delhi High Court Reins in Patent Claim Amendments: AbbVie’s Attempt to Convert Method Claims Rejected Introduction In a recent judgment in Abbvie Biotherapeutics INC & ANR. v. Assistant Controller of Patents and Designs [1]1, the Delhi High Court upheld the patent refusal order issued by the Controller of Patents for Indian patent application No. 201817047767, […]
Read more

Patent Lanscape 2023-24: Progress, Challenges and the Road Ahead

The Indian Patent Office (IPO) published its Annual Report on March 31, 2025 spanning activities from April 2023 to March 2024. The report showcases significant growth in filing of applications, expedited examinations and active international collaboration. This article summarizes the main insights from the year’s patent activity. Rising Patent Filings In 2023–24, 92,168 patent applications […]
Read more

Analyzing the Draft Computer-Related Inventions (CRI) Guidelines 2025 – Part 5: Determination of Excluded Subject Matter

Introduction This article is the final part of our multi-blog series on analyzing the Draft Computer-Related Inventions (CRI) Guidelines, 2025. Part 1 discusses the new definitions and terms introduced in the Guidelines, Part 2 discusses the judgments referred to in the Guidelines, Part 3 discusses the novelty and inventive step sections and Part 4 discusses […]
Read more

Analyzing the Draft Computer-related Inventions (CRI) Guidelines 2025 – Part 4: Sufficiency of Disclosure

Introduction This article is part 4 of our multi-blog series on analyzing the Draft Computer-Related Inventions (CRI) Guidelines, 2025. Part 1 discusses the new definitions and terms introduced in the Guidelines, Part 2 discusses the judgments referred to in the Guidelines, and Part 3 discusses the novelty and inventive step sections. On March 25, 2025, […]
Read more

Interpretation of Method Claim under Section 3(m) by Madras High Court – Robert Bosch Limited v. The Deputy Controller of Patents and Designs

Introduction The Indian Patents Act, 1970 states the inventions that are not eligible to be patented in India under Section 3. Section 3(m) states, a “mere scheme or rule or method of performing mental act or method of playing game [is not an invention].” Recently, in Robert Bosch Limited v. Deputy Controller of Patents and […]
Read more

Subscribe To Our Newsletter

Reach us at knk@kankrishme.com

knk@kankrishme.com
X